BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2024463)

  • 1. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA.
    Unger RE; Stout MW; Luciw PA
    Virology; 1991 May; 182(1):177-85. PubMed ID: 2024463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
    Furtado MR; Balachandran R; Gupta P; Wolinsky SM
    Virology; 1991 Nov; 185(1):258-70. PubMed ID: 1926777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1.
    Viglianti GA; Mullins JI
    J Virol; 1988 Dec; 62(12):4523-32. PubMed ID: 2846868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian immunodeficiency virus displays complex patterns of RNA splicing.
    Viglianti GA; Sharma PL; Mullins JI
    J Virol; 1990 Sep; 64(9):4207-16. PubMed ID: 2384918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
    Benko DM; Schwartz S; Pavlakis GN; Felber BK
    J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of biologically active simian immunodeficiency virus (SIV) Rev and Env in an SV40 system: the SIV rev gene regulates env expression.
    Cheng SM; Blume M; Lee SG; Hung PP; Hirsch VM; Johnson PR
    Virology; 1990 Aug; 177(2):816-9. PubMed ID: 2164737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of multiple mRNA species of simian immunodeficiency virus from macaques in a CD4+ lymphoid cell line.
    Park IW; Steen R; Li Y
    J Virol; 1991 Jun; 65(6):2987-92. PubMed ID: 1674547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
    Stephens RM; Derse D; Rice NR
    J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.
    Banapour B; Marthas ML; Ramos RA; Lohman BL; Unger RE; Gardner MB; Pedersen NC; Luciw PA
    J Virol; 1991 Nov; 65(11):5798-805. PubMed ID: 1920617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
    Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
    Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.
    Guan Y; Whitney JB; Detorio M; Wainberg MA
    J Virol; 2001 May; 75(9):4056-67. PubMed ID: 11287555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of simian immunodeficiency virus regulatory genes.
    Colombini S; Arya SK; Reitz MS; Jagodzinski L; Beaver B; Wong-Staal F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4813-7. PubMed ID: 2544874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells.
    Guatelli JC; Gingeras TR; Richman DD
    J Virol; 1990 Sep; 64(9):4093-8. PubMed ID: 2384914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of humoral immunity to SIVenv following simultaneous inoculation of mice by three recombinant adenoviruses encoding SIVenv/poliovirus chimeras, Tat and Rev.
    Chenciner N; Randrianarison-Jewtoukoff V; Delpeyroux F; Hanania N; Pedroza Martins L; Stratford Perricaudet L; Perricaudet M; Wain-Hobson S
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):801-6. PubMed ID: 9171225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
    Riggs NL; Little SJ; Richman DD; Guatelli JC
    Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames.
    Klase Z; Donio MJ; Blauvelt A; Marx PA; Jeang KT; Smith SM
    Retrovirology; 2006 Jan; 3():1. PubMed ID: 16398928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.